BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17645464)

  • 21. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
    McKenzie SJ; Baker MS; Buffinton GD; Doe WF
    J Clin Invest; 1996 Jul; 98(1):136-41. PubMed ID: 8690784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis.
    Kleinschmidt S; Meneses F; Nolte I; Hewicker-Trautwein M
    Vet Immunol Immunopathol; 2007 Dec; 120(3-4):80-92. PubMed ID: 17850882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
    Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease.
    Thakkar K; Lucia CJ; Ferry GD; McDuffie A; Watson K; Tsou M; Gilger MA
    Am J Gastroenterol; 2009 Mar; 104(3):722-7. PubMed ID: 19209163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells.
    Thienemann F; Henz BM; Babina M
    Arch Dermatol Res; 2004 Aug; 296(3):134-8. PubMed ID: 15322832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
    Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats.
    Ohashi K; Sato Y; Kawai M; Kurebayashi Y
    Life Sci; 2008 Feb; 82(7-8):419-23. PubMed ID: 18222490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas.
    Gibson JA; Hornick JL
    Am J Surg Pathol; 2009 May; 33(5):781-7. PubMed ID: 19065103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental stress causes mast cell degranulation, endothelial and epithelial changes, and edema in the rat intestinal mucosa.
    Wilson LM; Baldwin AL
    Microcirculation; 1999 Sep; 6(3):189-98. PubMed ID: 10501092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.
    Kirsch R; Bokhary R; Marcon MA; Cutz E
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):20-6. PubMed ID: 17204948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs.
    Moeser AJ; Ryan KA; Nighot PK; Blikslager AT
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G413-21. PubMed ID: 17525151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: implications for inflammatory bowel diseases.
    Orsó E; Moehle C; Boettcher A; Szakszon K; Werner T; Langmann T; Liebisch G; Buechler C; Ritter M; Kronenberg F; Dieplinger H; Bornstein SR; Stremmel W; Schmitz G
    Horm Metab Res; 2007 Aug; 39(8):601-11. PubMed ID: 17712726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
    Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.